Bordeaux Neurocampus > Scientific articles > CHRONIC TREATMENT WITH AN ANXIOLYTIC DOSE OF THE 5-HT(1A) AGONIST IPSAPIRONE DOES NOT ALTER IPSAPIRONE ACUTE NEUROENDOCRINE EFFECTS

CHRONIC TREATMENT WITH AN ANXIOLYTIC DOSE OF THE 5-HT(1A) AGONIST IPSAPIRONE DOES NOT ALTER IPSAPIRONE ACUTE NEUROENDOCRINE EFFECTS

B Schmidt
Psychoneuroendocrinology. 1993-01-01; 18(7): 457-466
DOI: 10.1016/0306-4530(93)90039-n

Know more about

January 1, 1993